COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )
8.040 -0.220 (-2.66%) Streaming Delayed Price Updated: 3:18 PM EDT, Jun 8, 2023 Add to My Watchlist
All News about COMPASS Pathways Plc - American Depository Shares
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
November 04, 2022
Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and...
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
November 03, 2022
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
November 03, 2022
From COMPASS Pathways
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since...
Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More
October 14, 2022
Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million...
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
October 12, 2022
Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following